1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East and Africa Travel Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East and Africa Travel Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East and Africa Travel Vaccines Market Regional Analysis
6.2 Middle East and Africa Travel Vaccines Market Revenue 2019-2028 (US$ Million)
6.3 Middle East and Africa Travel Vaccines Market Forecast Analysis
7. Middle East and Africa Travel Vaccines Market Analysis – by Product
7.1 Hepatitis A
- 7.1.1 Overview
- 7.1.2 Hepatitis A: Middle East and Africa Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Hepatitis B
- 7.2.1 Overview
- 7.2.2 Hepatitis B: Middle East and Africa Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Meningococcal Vaccines
- 7.3.1 Overview
- 7.3.2 Meningococcal Vaccines: Middle East and Africa Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Middle East and Africa Travel Vaccines Market Analysis – by Application
8.1 Domestic Travel and Outbound Travel
- 8.1.1 Overview
- 8.1.2 Domestic Travel and Outbound Travel : Middle East and Africa Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Middle East and Africa Travel Vaccines Market – Middle East and Africa Analysis
9.1 Overview
9.2 Middle East and Africa
- 9.2.1 Middle East and Africa Travel Vaccines Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 9.2.1.1 Middle East and Africa Travel Vaccines Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 South Africa:
Middle East and Africa Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 South Africa: Middle East and Africa Travel Vaccines Market Breakdown, by Product
- 9.2.1.1.2 South Africa: Middle East and Africa Travel Vaccines Market Breakdown, by Application
- 9.2.1.2 Saudi Arabia:
Middle East and Africa Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Saudi Arabia: Middle East and Africa Travel Vaccines Market Breakdown, by Product
- 9.2.1.2.2 Saudi Arabia: Middle East and Africa Travel Vaccines Market Breakdown, by Application
- 9.2.1.3 UAE:
Middle East and Africa Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 UAE: Middle East and Africa Travel Vaccines Market Breakdown, by Product
- 9.2.1.3.2 UAE: Middle East and Africa Travel Vaccines Market Breakdown, by Application
- 9.2.1.4 Rest of Middle East and Africa:
Middle East and Africa Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa Travel Vaccines Market Breakdown, by Product
- 9.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa Travel Vaccines Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Abbott
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Bharat Biotech
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 GlaxoSmithKline plc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Merck & Co., Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Novartis AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Pfizer Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Sanofi
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For Middle East and Africa Travel Vaccines Market
